GRT US Holding, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$16.3M
Doctors Paid
10,200
Transactions
28,935
2024 Total
$39,958
Payment Breakdown by Category
Research$12.0M (73.8%)
Consulting$1.4M (8.5%)
Travel$811,441 (5.0%)
Food & Beverage$662,114 (4.1%)
Royalty/License$13,888 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $12.0M | 2,206 | 73.8% |
| Consulting Fee | $1.4M | 253 | 8.5% |
| Honoraria | $1.2M | 488 | 7.2% |
| Travel and Lodging | $811,441 | 1,645 | 5.0% |
| Food and Beverage | $662,114 | 24,224 | 4.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $208,629 | 77 | 1.3% |
| Royalty or License | $13,888 | 6 | 0.1% |
| Grant | $3,000 | 1 | 0.0% |
| Education | $1,525 | 35 | 0.0% |
Payments by Type
Research
$12.0M
2,206 transactions
General
$4.3M
26,729 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE INTRAARTICULAR INJECTION OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $6.3M | 0 | 1,323 |
| KF7013-04 | $1.6M | 3 | 295 |
| KF7013-02 | $1.4M | 5 | 348 |
| PSNP | $1.1M | 0 | 4 |
| PSMP | $636,282 | 0 | 2 |
| AV001 | $430,482 | 0 | 169 |
| A SINGLEARM OPENLABEL PHASE III TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN SUBJECTS WITH MODERATE TO SEVERE PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $350,568 | 0 | 42 |
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $175,533 | 0 | 20 |
| Surgery Registry Study | $7,591 | 0 | 3 |
Payments by Medical Specialty
Top Paid Doctors — Page 3
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Timothy Mcalindon, Md, Mph, MD, MPH | Rheumatology | Worcester, MA | $11,862 | $0 |
| Marco Pappagallo, Md, MD | Neurology | New York, NY | $11,711 | $0 |
| Unknown Provider | — | — | $11,308 | $0 |
| Karina Gritsenko | Anesthesiology | Bronx, NY | $10,213 | $0 |
| Dr. Ellen Fields, M.d, M.D | Pediatrics | Silver Spring, MD | $9,625 | $0 |
| Dr. Shaheen Lakhan, Md, Phd, Faan, MD, PHD, FAAN | Neurology | Miami, FL | $9,500 | $0 |
| Dr. Thuan Le, M.d, M.D | Infectious Disease | Murrieta, CA | $9,407 | $0 |
| Unknown Provider | — | — | $8,988 | $0 |
| Miroslav Backonja, Md, MD | Pain Medicine | Seattle, WA | $8,227 | $0 |
| Brian Bruckner, M.d, M.D | Transplant Surgery | Hollywood, FL | $8,000 | $0 |
| Dr. Mark Wallace, Md, MD | Anesthesiology | San Diego, CA | $7,621 | $0 |
| Ms. Amanda Zimmerman, Pa-C, PA-C | Medical | Winston Salem, NC | $7,610 | $0 |
| Dr. Sachin Mehta, M.d, M.D | Physical Medicine & Rehabilitation | Indianapolis, IN | $7,068 | $0 |
| Dr. Joshua Prager, M.d, M.D | Pain Medicine | Los Angeles, CA | $6,585 | $0 |
| Dr. Yu Chiu, Md, MD | Physical Medicine & Rehabilitation | Newark, DE | $6,323 | $0 |
| Andrew Hesseltine, Md, MD | Pain Medicine | Colton, CA | $6,000 | $0 |
| Steven Cohen, M.d, M.D | Anesthesiology | Chicago, IL | $5,860 | $0 |
| Thomas Harris, Dds, DDS | Dentist | Palatine, IL | $5,600 | $0 |
| Dr. Peter Staats, M.d, M.D | Pain Medicine | Shrewsbury, NJ | $5,495 | $0 |
| Dr. Andrew Morchower, M.d, M.D | Interventional Pain Medicine | Frisco, TX | $5,167 | $0 |
| Dr. Vivek Bansal, M.d., Mph, Face, M.D., MPH, FACE | Endocrinology, Diabetes & Metabolism | Edison, NJ | $5,149 | $0 |
| John Markman, Md, MD | Neurology | Rochester, NY | $5,100 | $0 |
| Dr. Javan Bass, Dpm, DPM | Foot & Ankle Surgery | Lithonia, GA | $5,052 | $0 |
| Dr. Tolga Suvar | Anesthesiology | Chicago, IL | $5,032 | $0 |
| Dr. Qing Jia, M.d, M.D | Internal Medicine | Garland, TX | $4,861 | $0 |
Ad
Top Products
- Qutenza $5.7M
- Neridronic acid $2.7M
Associated Products (4)
- Qutenza $5.7M
- Neridronic acid $2.7M
- Nerizonate $290,129
- Cutis $13,262
Payment Categories
- Food & Beverage $662,114
- Consulting $1.4M
- Travel & Lodging $811,441
- Research $12.0M
- Royalties $13,888
About GRT US Holding, Inc.
GRT US Holding, Inc. has made $16.3M in payments to 10,200 healthcare providers, recorded across 28,935 transactions in the CMS Open Payments database. In 2024, the company paid $39,958. The top product by payment volume is Qutenza ($5.7M).
Payments were distributed across 167 medical specialties. The top specialty by payment amount is Pain Medicine ($910,294 to 837 doctors).
Payment categories include: Food & Beverage ($662,114), Consulting ($1.4M), Research ($12.0M), Travel & Lodging ($811,441), Royalties ($13,888).
GRT US Holding, Inc. is associated with 4 products in the CMS Open Payments database, including Qutenza, Neridronic acid, and Nerizonate.